Somatostatin receptors in the ventral pallidum/substantia innominata modulate rat locomotor activity
dc.contributor.author | Marazioti, A. | en |
dc.contributor.author | Kastellakis, A. | en |
dc.contributor.author | Antoniou, K. | en |
dc.contributor.author | Papasava, D. | en |
dc.contributor.author | Thermos, K. | en |
dc.date.accessioned | 2015-11-24T18:51:00Z | |
dc.date.available | 2015-11-24T18:51:00Z | |
dc.identifier.issn | 0033-3158 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18191 | |
dc.rights | Default Licence | - |
dc.subject | Animals | en |
dc.subject | Dose-Response Relationship, Drug | en |
dc.subject | Globus Pallidus/drug effects/*physiology/surgery | en |
dc.subject | Injections, Intraventricular | en |
dc.subject | Male | en |
dc.subject | Motor Activity/drug effects/*physiology | en |
dc.subject | Oligopeptides/pharmacology | en |
dc.subject | Peptides, Cyclic/pharmacology | en |
dc.subject | Piperazines/pharmacology | en |
dc.subject | Quinolines/pharmacology | en |
dc.subject | Rats | en |
dc.subject | Rats, Sprague-Dawley | en |
dc.subject | Receptors, Somatostatin/antagonists & inhibitors/*physiology | en |
dc.subject | Somatostatin/administration & dosage/analogs & derivatives/pharmacology | en |
dc.subject | Stereotaxic Techniques | en |
dc.subject | Substantia Innominata/drug effects/*physiology | en |
dc.subject | Time Factors | en |
dc.title | Somatostatin receptors in the ventral pallidum/substantia innominata modulate rat locomotor activity | en |
heal.abstract | RATIONALE: Somatostatin and its receptors (sst(1) and sst(2)) have been localized in brain nuclei implicated in motor control, such as the nucleus accumbens, ventral pallidum (VP) and substantia innominata (SI). OBJECTIVES: The objective of the study is to investigate the effect of somatostatin and selective sst(1) and sst(2) analogs infused in the VP/SI on the locomotor activity of the rat. METHODS: Somatostatin (15, 30, 60, 120 and 240 ng/0.5 microl/side), CH275 (sst(1) analog; 60, 180, 240 and 480 ng/0.5 microl/side), MK678 (sst(2) analog; 120, 240 and 480 ng/0.5 microl/side), L-809,087 (sst(4) agonist, 240 ng/0.5 microl/side) or saline (vehicle) were infused bilaterally in the VP/SI of the rat and locomotor activity measured for 60 min. The effect of SRA-880 (sst(1) antagonist) and CYN-154806 (sst(2) antagonist) on somatostatin-, CH275- and MK678-mediated locomotor activity was also ascertained. RESULTS: Somatostatin decreased locomotor activity in the first 30 min after its infusion in the VP/SI and in a dose-dependent manner. The sst(1) and sst(2) antagonists, SRA-880 and CYN-154806, respectively, reversed the somatostatin effect. The sst(1) and sst(2) agonists CH275 and MK678, respectively, mimicked somatostatin's actions, while the selective sst(4) agonist L-809,087 had no effect. Moreover, SRA-880 and CYN-154806 reversed the respective agonist action on locomotor activity. CONCLUSION: The present study provides functional evidence for the presence of sst(1) and sst(2) receptors in the VP/SI and their implication in motor control. The mechanism via which somatostatin and agonists mediate the attenuation of locomotor activity is presently being investigated. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | 10.1007/s00213-005-2237-z | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/15778878 | - |
heal.identifier.secondary | http://www.springerlink.com/content/j5640gh26g026721/fulltext.pdf | - |
heal.journalName | Psychopharmacology (Berl) | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2005 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: